Skip to main content
BIFIDO. Co. Ltd logo

BIFIDO. Co. Ltd — Investor Relations & Filings

Ticker · 238200 ISIN · KR7238200000 KO Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2025-03-12 Audit Report / Informat…
Country KR South Korea
Listing KO 238200

About BIFIDO. Co. Ltd

https://bifido.com/

BIFIDO Co., Ltd. is a biotechnology company established in 1999 that specializes in the human microbiome. The company's core focus is the research and development of human-derived Bifidobacterium strains for use in functional foods, supplements, and personal care products. BIFIDO operates an integrated platform that covers the entire process from the selection of probiotic and pharmabiotic candidates to the manufacturing of finished goods, marketed under brands like BIFIDOLAB. Its research, supported by extensive scientific papers and patents, targets areas such as immune regulation, cognitive health, and the development of microbiome-based therapeutics for various health conditions.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion, financial highlights (assets, liabilities, equity, profit/loss), and auditor information for the fiscal year. While it contains financial data, it is a standardized regulatory disclosure form announcing the receipt and submission of the audit report rather than the full, multi-page audit report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2024
2025-03-12 Korean
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Bifido Co., Ltd. for the fiscal year ending December 31, 2024. It includes the independent auditor's report, consolidated financial statements (statement of financial position, comprehensive income, changes in equity, cash flows), and detailed notes. This is a comprehensive financial document, not an announcement or a summary, and fits the definition of an Audit Report (AR) as it contains the auditor's opinion and the audited financial statements. FY 2024
2025-03-12 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Bifido Co., Ltd. It contains the meeting agenda, details on electronic voting, and management reference materials including financial statements (balance sheet, income statement, etc.) for the 26th fiscal year. While it contains financial data, it is primarily a proxy solicitation document sent to shareholders to inform them of the upcoming meeting and request their votes. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2025-03-05 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'Bifido'. It outlines the date, location, and agenda items (such as financial statement approval and director compensation) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of the upcoming meeting and the items to be voted upon.
2025-02-26 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Bifido) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement for listed companies in Korea to report preliminary financial results before the final audit is completed. Since it provides key financial highlights (revenue, operating profit, net income) for the fiscal year, it falls under the 'Earnings Release' category. FY 2024
2025-02-26 Korean
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the company 'Bifido' regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment amount and completion date for a construction project (Bifido Microbiome Center). Since this is a specific corporate announcement regarding capital expenditure and facility investment, it falls under the category of general regulatory filings that do not fit into more specific financial reporting categories like earnings or dividends.
2024-12-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.